For years, diabetic kidney disease (DKD) has been viewed as a single condition that progresses in a fairly predictable way. However, new research suggests that this assumption may overlook important biological differences between patients. Scientists have now identified a previously hidden subtype of diabetic kidney disease marked by increased B-cell …
Read More »Farxiga Just Went Generic—Will Lower Prices Finally Change Diabetes Care?
For many people living with type 2 diabetes, the biggest challenge is not finding an effective medication. It is being able to afford it. That reality may begin to change now that the U.S. Food and Drug Administration (FDA) has approved the first generic versions of Farxiga (dapagliflozin), potentially making …
Read More »When Cardiology Meets Endocrinology: Why Diabetes Care Is Becoming a Team Sport
Not long ago, diabetes management focused primarily on controlling blood glucose levels. Today, that approach has evolved dramatically as cardiologists and endocrinologists increasingly work together to reduce cardiovascular risk. Thanks to groundbreaking cardiovascular outcome trials (CVOTs), clinicians now understand that treating type 2 diabetes means protecting the heart, kidneys, and …
Read More »Beyond SGLT2 Inhibitors: Why Non-Steroidal MRAs Are Becoming the Third Pillar of Kidney Protection
For years, the treatment of diabetic kidney disease focused primarily on glycemic control and blood pressure management. More recently, SGLT2 inhibitors and GLP-1 receptor agonists have transformed the landscape by reducing kidney disease progression and cardiovascular events. However, another therapeutic class is rapidly gaining recognition. Non-steroidal mineralocorticoid receptor antagonists (MRAs) …
Read More »Getting to 120 Safely: A Practical Guide to Intensive Blood Pressure Management in Diabetes
Blood pressure control remains one of the most powerful tools for reducing cardiovascular and kidney complications in people with diabetes. While clinicians have traditionally focused on achieving targets below 140/90 mmHg, recent evidence and the 2026 American Diabetes Association Standards of Care support a more intensive approach for selected high-risk …
Read More »When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus
Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …
Read More »Addressing the Challenge of Diabetic Kidney Disease: From Diagnosis to Management
Diabetic kidney disease is a serious complication of diabetes that can lead to end-stage kidney failure. It is one of the leading causes of morbidity and mortality among individuals with diabetes. As such, it is critical to understand the diagnosis and management of diabetic kidney disease in order to ensure …
Read More »Microvascular Complications in Diabetes: Screening and Management
Diabetes is a chronic condition affecting millions of people worldwide. One of the most serious complications of diabetes is microvascular disease, which can cause damage to the small blood vessels in the body and lead to a range of serious health problems. To help prevent and manage microvascular complications, it …
Read More »Managing Diabetes and Chronic Kidney Disease
Diabetes and chronic kidney disease (CKD) are two of the most common chronic illnesses in the world. Both can have serious consequences if left untreated, but proper management can help reduce the risk of further complications. This article will provide an overview of diabetes and CKD, discuss risk factors for …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.